A multivariate approach to prognostication in experimental bacterial meningitis

Area of Science:

• Infectious Disease
• Neurology
• Clinical Chemistry

Background:

• Bacterial meningitis, particularly pneumococcal meningitis, poses significant health risks.
• Accurate prognostication is crucial for effective patient management and treatment strategies.

Purpose of the Study:

• To evaluate the prognostic utility of various cerebrospinal fluid (CSF) and plasma biomarkers in a rabbit model of type III pneumococcal meningitis.
• To determine the optimal timing for biomarker analysis to predict outcomes.

Main Methods:

• Eighty-one rabbits were inoculated with type III pneumococci and treated with antibiotics.
• CSF and plasma samples were collected at regular intervals (up to eight days) post-inoculation.
• Analyzed biomarkers included glucose, lactate, lactic dehydrogenase, creatine kinase, and leukocyte counts.

Main Results:

• The timing of sample collection was critical for prognostic accuracy.
• Day two plasma glucose emerged as the single most important predictor of outcome.
• Day one CSF glucose, lactate, and leukocyte counts also demonstrated significant prognostic value.
• Combining multiple clinical laboratory measurements using discriminant function analysis substantially improved prognostic accuracy.

Conclusions:

• Biomarker analysis in CSF and plasma, particularly early in the course of infection, can provide valuable prognostic information in pneumococcal meningitis.
• Plasma glucose levels on day two are a key indicator for predicting outcomes.
• Multivariate analysis of combined biomarkers enhances predictive capabilities for disease prognosis.